Correction Open Access
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Oct 15, 2022; 14(10): 2085-2087
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.2085
Correction to “Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancreatic cancer progression via IRS1/AKT axis”
Bu-Wei Teng, Department of General Surgery, Shanghai General Hospital of Nanjing Medical University, Shanghai 200080, China
Bu-Wei Teng, Department of General Surgery, Lianyungang Clinical College of Nanjing Medical University/The First People’s Hospital of Lianyungang, Lianyungang 222061, Jiangsu Province, China
Kun-Dong Zhang, Yu-Han Yang, Zeng-Ya Guo, Wei-Wei Chen, Zheng-Jun Qiu, Department of General Surgery, Shanghai General Hospital, Shanghai 200080, China
ORCID number: Bu-Wei Teng (0000-0002-9555-2830); Kun-Dong Zhang (0000-0002-2232-2153); Yu-Han Yang (0000-0002-3717-5088); Zeng-Ya Guo (0000-0001-8310-5147); Wei-Wei Chen (0000-0001-8325-5663); Zheng-Jun Qiu (0000-0002-8318-847X).
Author contributions: Teng BW found and corrected the misused figure; Zhang KD, Yang YH, Guo ZY, Chen WW, and Qiu ZJ checked the correction.
Conflict-of-interest statement: There are no conflicts of interest to report.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Zheng-Jun Qiu, MD, Chief Doctor, Director, Surgeon, Department of General Surgery, Shanghai General Hospital, No. 100 Haining Road, Shanghai 200080, China. zhengjun.qiu@shgh.cn
Received: April 6, 2022
Peer-review started: April 6, 2022
First decision: June 12, 2022
Revised: June 15, 2022
Accepted: September 13, 2022
Article in press: September 13, 2022
Published online: October 15, 2022
Processing time: 190 Days and 4.5 Hours

Abstract

Correction to “Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancreatic cancer progression via IRS1/AKT axis” (PMID: 34853645 PMCID: PMC8603463 DOI: 10.4251/wjgo.v13.i11.1709). In this article, the picture of Figure 6C was misused due to our carelessness while typesetting. We corrected this mistake, and replaced the incorrect image with the correct one.

Key Words: Correction; Error; Figure; CRISPR-Cas9

Core Tip: Correction to “Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancreatic cancer progression via IRS1/AKT axis.”



TO THE EDITOR

After confirming the figures in our manuscript, we were surprised to find a mistake in Figure 6C[1]. It was an unintentional error that occurred when we typeset the images. We have replaced the incorrect images with the correct Figure 6C (Figure 1). Figure 6D-E was based on the correct image and does not need to be changed. We assure you that this mistake does not change the meaning of the picture or the conclusion of the manuscript. We apologize for our careless mistake, which has caused great inconvenience.

Figure 1
Figure 1 We replaced the incorrect images with the correct Figure 6C in “Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancreatic cancer progression via IRS1/AKT axis.”
Footnotes

Provenance and peer review: Unsolicited article; Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Oncology

Country/Territory of origin: China

Peer-review report’s scientific quality classification

Grade A (Excellent): A

Grade B (Very good): B

Grade C (Good): C

Grade D (Fair): 0

Grade E (Poor): 0

P-Reviewer: Liu H, United States; Solimando AG, Italy; Trna J, Czech Republic S-Editor: Chen YL L-Editor: Filipodia P-Editor: Chen YL

References
1.  Teng BW, Zhang KD, Yang YH, Guo ZY, Chen WW, Qiu ZJ. Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancreatic cancer progression via IRS1/AKT axis. World J Gastrointest Oncol. 2021;13:1709-1724.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in CrossRef: 4]  [Cited by in F6Publishing: 3]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]